Ekso Bionics Holdings, Inc. (EKSO)
USD 0.63
(-11.99%)
USD 0.63
(-11.99%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 5.05 Million USD | -2.64% |
| 2022 | 5.18 Million USD | 131.36% |
| 2021 | 2.24 Million USD | 13.35% |
| 2020 | 1.97 Million USD | -20.53% |
| 2019 | 2.48 Million USD | -26.16% |
| 2018 | 3.37 Million USD | 11.44% |
| 2017 | 3.02 Million USD | 94.41% |
| 2016 | 1.55 Million USD | 47.35% |
| 2015 | 1.05 Million USD | 69.77% |
| 2014 | 622 Thousand USD | -14.21% |
| 2013 | 725 Thousand USD | 17.82% |
| 2012 | 615.36 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 5.03 Million USD | 1.15% |
| 2024 Q2 | 4.97 Million USD | -2.59% |
| 2024 Q1 | 5.1 Million USD | 1.11% |
| 2023 Q2 | 5.6 Million USD | -1.06% |
| 2023 Q4 | 5.05 Million USD | -7.96% |
| 2023 FY | 5.05 Million USD | -2.64% |
| 2023 Q1 | 5.66 Million USD | 9.16% |
| 2023 Q3 | 5.48 Million USD | -2.05% |
| 2022 Q1 | 2.77 Million USD | 23.64% |
| 2022 Q4 | 5.18 Million USD | 47.86% |
| 2022 Q3 | 3.5 Million USD | 7.15% |
| 2022 FY | 5.18 Million USD | 131.36% |
| 2022 Q2 | 3.27 Million USD | 18.11% |
| 2021 Q4 | 2.24 Million USD | 28.04% |
| 2021 Q1 | 2.15 Million USD | 8.9% |
| 2021 FY | 2.24 Million USD | 13.35% |
| 2021 Q3 | 1.75 Million USD | -10.34% |
| 2021 Q2 | 1.95 Million USD | -9.33% |
| 2020 Q3 | 2.18 Million USD | -8.56% |
| 2020 Q2 | 2.38 Million USD | -3.99% |
| 2020 FY | 1.97 Million USD | -20.53% |
| 2020 Q4 | 1.97 Million USD | -9.27% |
| 2020 Q1 | 2.48 Million USD | -0.24% |
| 2019 Q4 | 2.48 Million USD | -25.52% |
| 2019 FY | 2.48 Million USD | -26.16% |
| 2019 Q3 | 3.34 Million USD | -10.26% |
| 2019 Q2 | 3.72 Million USD | 12.85% |
| 2019 Q1 | 3.3 Million USD | -2.11% |
| 2018 Q2 | 2.38 Million USD | -15.92% |
| 2018 Q1 | 2.83 Million USD | -6.35% |
| 2018 Q4 | 3.37 Million USD | 0.3% |
| 2018 FY | 3.37 Million USD | 11.44% |
| 2018 Q3 | 3.36 Million USD | 41.1% |
| 2017 Q4 | 3.02 Million USD | 27.21% |
| 2017 Q1 | 1.81 Million USD | 16.9% |
| 2017 Q3 | 2.37 Million USD | 25.42% |
| 2017 FY | 3.02 Million USD | 94.41% |
| 2017 Q2 | 1.89 Million USD | 4.23% |
| 2016 Q1 | 2.53 Million USD | 139.68% |
| 2016 Q2 | 2.4 Million USD | -4.86% |
| 2016 Q4 | 1.55 Million USD | -18.75% |
| 2016 Q3 | 1.91 Million USD | -20.47% |
| 2016 FY | 1.55 Million USD | 47.35% |
| 2015 Q3 | 1.17 Million USD | -0.76% |
| 2015 Q2 | 1.18 Million USD | 41.77% |
| 2015 Q1 | 838 Thousand USD | 34.73% |
| 2015 FY | 1.05 Million USD | 69.77% |
| 2015 Q4 | 1.05 Million USD | -10.43% |
| 2014 Q4 | 622 Thousand USD | -28.04% |
| 2014 Q2 | 1.27 Million USD | 13.71% |
| 2014 Q1 | 1.12 Million USD | 54.9% |
| 2014 FY | 622 Thousand USD | -14.21% |
| 2014 Q3 | 864.39 Thousand USD | -32.31% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | 725 Thousand USD | -19.91% |
| 2013 FY | 725 Thousand USD | 17.82% |
| 2013 Q1 | - USD | -100.0% |
| 2013 Q3 | 905.24 Thousand USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 615.36 Thousand USD | 0.0% |
| 2012 Q4 | 615.36 Thousand USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 71.751% |
| AngioDynamics, Inc. | 60.61 Million USD | 91.669% |
| AtriCure, Inc. | 67.89 Million USD | 92.562% |
| Avinger, Inc. | 5.29 Million USD | 4.681% |
| Azenta, Inc. | 128.19 Million USD | 96.061% |
| BioLife Solutions, Inc. | 43.45 Million USD | 88.379% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.313% |
| Daxor Corporation | - USD | -Infinity% |
| Femasys Inc. | 667.11 Thousand USD | -656.988% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 79.568% |
| Hologic, Inc. | 679.8 Million USD | 99.257% |
| ICU Medical, Inc. | 709.36 Million USD | 99.288% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.586% |
| KORU Medical Systems, Inc. | 3.48 Million USD | -45.061% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 90.35% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -489.431% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -489.431% |
| Masimo Corporation | 545 Million USD | 99.073% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -212.263% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 98.338% |
| Nephros, Inc. | 2.47 Million USD | -104.453% |
| NovoCure Limited | 38.15 Million USD | 86.763% |
| NEXGEL, Inc. | 1.31 Million USD | -282.866% |
| NEXGEL, Inc. | 1.31 Million USD | -282.866% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 62.791% |
| OraSure Technologies, Inc. | 47.61 Million USD | 89.394% |
| Pro-Dex, Inc. | 15.26 Million USD | 66.926% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -921.494% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | -76.075% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.126% |
| Repligen Corporation | 202.32 Million USD | 97.504% |
| Sanara MedTech Inc. | 4.71 Million USD | -7.047% |
| STAAR Surgical Company | 35.13 Million USD | 85.625% |
| Sharps Technology, Inc. | 1.7 Million USD | -195.471% |
| Utah Medical Products, Inc. | 9.58 Million USD | 47.297% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.191% |
| Jin Medical International Ltd. | 5.05 Million USD | 0.062% |